Impacts of geniposide on proliferation, apoptosis, and autophagy in lung cancer cells via the AMPK / mTOR / ULK1 pathway
CSTR:
Author:
Affiliation:

1. Thoracic Surgery Department, Shengli Oilfield Central Hospital, Dongying 257000, China. 2. Oncology Department,Shengli Oilfield Central Hospital, Dongying 257000. 3. Surgery Department, Shengli Oilfield Central Hospital,Dongying 257000

Clc Number:

R-33

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To discuss the effects of geniposide on proliferation, apoptosis, and autophagy in lung cancer cells by regulating the adenosine monophosphate-activated protein kinase (AMPK) / mammalian target of rapamycin (mTOR) / unc-51 like kinase 1 (ULK1) pathway. Methods A549 cells were divided into lung cancer,low-dose geniposide, medium-dose geniposide, high-dose geniposide, AMPK activator (MK8722), and high-dose geniposide+AMPK inhibitor (Compound C) groups. 5-Ethynyl-2’ deoxyuridine (EdU) staining and CCK-8 assays were used to detect cell proliferation. Flow cytometry was used to detect cell apoptosis. Transmission electron microscopy was used to count autophagosomes in A549 cells. RT-qPCR was used to detect the mRNA expression of proliferating cell nuclear antigen ( PCNA), p53, p62, and Bcl-2 homologous domain protein ( Beclin1) in A549 cells. Western blot was used to detect microtubule associated protein 1 light chain 3 (LC3), p-AMPK, p-mTOR, and p-ULK1 in A549 cells. Results Compared with levels in the lung cancer group, the low-, medium-, and high-dose geniposide groups showed decreases in the EdU-positive rate, OD450 value, PCNA and p62 mRNA levels, and pmTOR protein expression in A549 cells and increases in the apoptosis rate, autophagosome number, p53 and Beclin1 mRNA levels, and LC3-II/ LC3-I, p-AMPK, and p-ULK1 protein levels; the high-dose geniposide group showed the most prominent differences (P<0. 05). Compared with levels in the lung cancer group, the MK8722 group showed decreases in the EdU-positive rate, OD450 value, PCNA and p62 mRNA levels, and p-mTOR protein expression in A549 cells and increases in the apoptosis rate, autophagosome number, p53 and Beclin1 mRNA levels(P<0. 05), and LC3-II/ LC3-I, p-AMPK, and p-ULK1 protein levels ( P< 0. 05). Compared with levels in the high-dose geniposide group, the high-dose geniposide+Compound C group showed increases in the EdU-positive rate, OD450 value, PCNA and p62 mRNA levels, and p-mTOR protein levels in A549 cells and decreases in the apoptosis rate,autophagosome number, p53 and Beclin1 mRNA levels ( P< 0. 05), and LC3-II/ LC3-I, p-AMPK, and p-ULK1 protein levels (P<0. 05). Conclusions Geniposide may inhibit A549 cell proliferation and promote autophagy and apoptosis through activating the AMPK/ mTOR/ ULK1 pathway.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:May 15,2025
  • Revised:
  • Adopted:
  • Online: December 12,2025
  • Published:
Article QR Code